GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abattis Bioceuticals Corp (OTCPK:ATTBF) » Definitions » Cyclically Adjusted Price-to-FCF

Abattis Bioceuticals (Abattis Bioceuticals) Cyclically Adjusted Price-to-FCF : (As of Jun. 07, 2024)


View and export this data going back to . Start your Free Trial

What is Abattis Bioceuticals Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abattis Bioceuticals Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abattis Bioceuticals Cyclically Adjusted Price-to-FCF Chart

Abattis Bioceuticals Annual Data
Trend Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abattis Bioceuticals Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF falls into.



Abattis Bioceuticals Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Abattis Bioceuticals's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2019 is calculated as:

For example, Abattis Bioceuticals's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2019 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2019 (Change)*Current CPI (Sep. 2019)
=-0.002/107.6113*107.6113
=-0.002

Current CPI (Sep. 2019) = 107.6113.

Abattis Bioceuticals Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
200912 -0.025 90.703 -0.030
201003 -0.005 91.335 -0.006
201006 -0.006 91.809 -0.007
201009 -0.024 92.362 -0.028
201012 -0.024 92.836 -0.028
201103 -0.016 94.338 -0.018
201106 -0.008 94.654 -0.009
201109 -0.005 95.286 -0.006
201112 -0.001 94.970 -0.001
201203 -0.018 96.155 -0.020
201206 -0.004 96.076 -0.004
201209 0.000 96.392 0.000
201212 -0.006 95.760 -0.007
201303 -0.003 97.103 -0.003
201306 -0.001 97.182 -0.001
201309 0.000 97.419 0.000
201312 0.000 96.945 0.000
201403 -0.006 98.604 -0.007
201406 -0.015 99.473 -0.016
201409 -0.012 99.394 -0.013
201412 -0.011 98.367 -0.012
201503 0.000 99.789 0.000
201506 -0.004 100.500 -0.004
201509 -0.007 100.421 -0.008
201512 -0.004 99.947 -0.004
201603 -0.004 101.054 -0.004
201606 0.000 102.002 0.000
201609 0.000 101.765 0.000
201612 -0.001 101.449 -0.001
201703 -0.002 102.634 -0.002
201706 -0.001 103.029 -0.001
201709 -0.002 103.345 -0.002
201712 -0.013 103.345 -0.014
201803 -0.001 105.004 -0.001
201806 -0.007 105.557 -0.007
201809 -0.003 105.636 -0.003
201812 -0.002 105.399 -0.002
201903 -0.001 106.979 -0.001
201906 0.012 107.690 0.012
201909 -0.002 107.611 -0.002

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abattis Bioceuticals  (OTCPK:ATTBF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Abattis Bioceuticals Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Abattis Bioceuticals (Abattis Bioceuticals) Business Description

Traded in Other Exchanges
N/A
Address
1200 - 625 Howe Street, Vancouver, BC, CAN, V6C 2M6
Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.